Norton Rose Fulbright has advised Velocity Clinical Research on the deal.Velocity Clinical Research (Velocity), a portfolio company of GHO Capital (Global Healthcare Opportunities), Europe’s leading private…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
